medigraphic.com
ISSN 2395-8723 (Digital)
ISSN 1405-888X (Impreso)
TIP Revista Especializada en Ciencias Químico-Biológicas

2023, Número 1

<< Anterior Siguiente >>

TIP Rev Esp Cienc Quim Biol 2023; 26 (1)


Identificación de factores asociados al aumento de la expresión génica de CRABP1 en pacientes con lesiones intraepiteliales escamosas y cáncer de cuello uterino

Arellano-Ortiz AL, Jiménez-Vega F, Salcedo-Vargas M, Muñiz-Hernández S

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 1-13
Archivo PDF: 484.02 Kb.


RESUMEN

La unión celular de la proteína con el ácido retinoico-1 (CRABP1) facilita el metabolismo de los retinoides y de su expresión anormal podría resultar en diversos cánceres. Para el caso que nos ocupa se evaluaron muestras de las biopsias de pacientes con cáncer de cuello uterino (CC) y con lesiones intraepiteliales escamosas de alto (HSIL) y de bajo grado (LSIL) (n= 66), por lo que para realizar el estudio se obtuvo la información clínico-patológica de las mujeres. La expresión del gen CRABP1 se examinó mediante RT-PCR y la proteína por inmunohistoquímica (IHC). La expresión de CRABP1 resultó ser más baja en el grupo HSIL significativamente (p = 0.008). La expresión proteica de CRABP1 se observó en el 90.3% de los tejidos, y en el CC su ausencia fue de un 9.7%. El aumento de la expresión génica, así como la disminución de la cantidad de proteína en este tipo de cáncer varía en diferentes situaciones médicas de acuerdo a lo observado: en el sobrepeso/obesidad aumenta la expresión génica (p= 0.019), pero no en la proteína (p = 0.053). Además, se mostró un aumento de la expresión CRABP1 con una concentración alta de retinol (p= 0.047) y la presencia de HVP-16 (p= 0.011) (expresión génica pero no la proteína, p › 0.05). Pacientes con menopausia se asociaron con la ausencia/débil inmunotinción de la proteína CRABP1 (p= 0.008). Finalmente, concluimos que CRABP1 y los factores asociados pueden ser útiles como biomarcadores para rastrear la progresión y la persistencia del cáncer de cuello uterino en el tejido.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Abu, J., Batuwangala, M., Herbert, K. & Symonds, P.(2005) Retinoic acid and retinoid receptors: potentialchemopreventive and therapeutic role in cervical cancer.Lancet Oncol., 6(9), 712–20.

  2. Aziz, S. W. & Aziz, M. H. (2017). Cervical Cancer Metastasis. InA. Ahmad (Ed.), Introduction to Cancer Metastasis. ElsevierInc. https://doi.org/10.1016/B978-0-12-804003-4.00005-0

  3. Balmer, J. E. & Blomhoff, R. (2002). Gene expression regulationby retinoic acid. J. Lipid Res., 43(11), 1773–1808. https://doi.org/10.1194/jlr.r100015-jlr200

  4. Bi, J., Hu, X., Zhou, F. C. & Wei, L. N. (2001). Upregulationof cellular retinoic acid-binding protein I expression byethanol. Dev. Growth Differ., 43(5), 553–561. https://doi.org/doi.org/10.1046/j.1440-169X.2001.00591.x

  5. Blaese, M. A., Santo-Hoeltje, L. & Rodemann, H. P. (2003).CRABP I expression and the mediation of the sensitivityof human tumour cells to retinoic acid and irradiation. Int.J. Radiat. Biol., 79(12), 981–991. https://doi.org/10.1080/09553000310001632949

  6. Celestino, R., Nome, T., Pestana, A., Hoff, A. M., Gonçalves, A.P., Pereira, L., Cavadas, B., Eloy, C., Bjøro, T., Sobrinho-Simões, M., Skotheim, R. I. & Soares, P. (2018). CRABP1,C1QL1 and LCN2 are biomarkers of differentiated thyroidcarcinoma, and predict extrathyroidal extension. BMCCancer, 18(1), 68. https://doi.org/10.1186/s12885-017-3948-3

  7. Clarke, M. A., Fetterman, B., Cheung, L. C., Wentzensen,N., Gage, J. C., Katki, H. A., Befano, B., Demarco, M.,Schussler, J., Kinney, W. K., Raine-Bennett, T. R., Lorey,T. S., Poitras, N. E., Castle, P. E. & Schiffman, M. (2018).Epidemiologic Evidence That Excess Body WeightIncreases Risk of Cervical Cancer by Decreased Detectionof Precancer. J. Clin. Oncol., 36(12), 1184–1191. https://doi.org/10.1200/JCO.2017.75.3442

  8. Darroudi, F., Bergs, J. W. J., Bezrookove, V., Buist, M. R.,Stalpers, L. J. & Franken, N. A. P. (2010). PCC andCOBRA-FISH a new tool to characterize primary cervicalcarcinomas: To assess hall-marks and stage specificity.Cancer Letters, 287(1), 67–74. https://doi.org/https://doi.org/10.1016/j.canlet.2009.05.034

  9. Enikeev, A. D., Komelkov, A. V., Axelrod, M. E., Galetsky, S.A., Kuzmichev, S. A. & Tchevkina, E. M. (2021). CRABP1and CRABP2 Protein Levels Correlate with Each Other butDo Not Correlate with Sensitivity of Breast Cancer Cellsto Retinoic Acid. Biochemistry (Mosc.), 86(2), 217–229.https://doi.org/10.1134/S0006297921020103

  10. Favorskaya, I., Kainov, Y., Chemeris, G., Komelkov, A.,Zborovskaya, I. & Tchevkina, E. (2014). Expression andclinical significance of CRABP1 and CRABP2 in nonsmallcell lung cancer. Tumour Biol., 35(10), 10295–10300.https://doi.org/10.1007/s13277-014-2348-4

  11. Hillemanns, P., Tannous-Khuri, L., Koulos, J. P., Talmage, D.& Wright, T. C. (1992). Localization of cellular retinoidbindingproteins in human cervical intraepithelial neoplasiaand invasive carcinoma. Am. J. Pathol., 141(4), 973–980.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1886642/

  12. Idres, N., Marill, J., Flexor, M. & Chabot, G. G. (2002).Activation of retinoic acid receptor-dependent transcriptionby all-trans-retinoic acid metabolites and isomers. J. Biol.Chem., 277(35), 31491–31498. https://doi.org/doi: 10.1074/jbc.M205016200

  13. Langton, S. & Gudas, L. J. (2008). CYP26A1 knockoutembryonic stem cells exhibit reduced differentiation andgrowth arrest in response to retinoic acid. Dev. Biol., 315(2),331–354. https://doi.org/doi: 10.1016/j.ydbio.2007.12.021.

  14. Lin, Y.-W., Park, S. W., Lin, Y.-L., Burton, F. H. & Wei, L.-N.(2020). Cellular retinoic acid binding protein 1 protects micefrom high-fat diet-induced obesity by decreasing adipocytehypertrophy. Int. J. Obes. (Lond.), 44(2), 466–474. https://doi.org/10.1038/s41366-019-0379-z

  15. Liu, R.-Z., Garcia, E., Glubrecht, D. D., Poon, H. Y., Mackey,J. R. & Godbout, R. (2015). CRABP1 is associated with apoor prognosis in breast cancer: adding to the complexityof breast cancer cell response to retinoic acid. Mol. Cancer,14(1), 129. https://doi.org/10.1186/s12943-015-0380-7

  16. Meyerholz, D. K. & Beck, A. P. (2018). Principles and approachesfor reproducible scoring of tissue stains in research. Lab.Invest., 98, 844–855. https://doi.org/10.1038/s41374-018-0057-0

  17. Michalaki, M. A., Vagenakis, A. G., Leonardou, A. S., Argentou,M. N., Habeos, I. G., Makri, M. G., Psyrogiannis, A. I.,Kalfarentzos, F. E. & Kyriazopoulou, V. E. (2006). Thyroidfunction in humans with morbid obesity. Thyroid, 16(1),73–78. https://doi.org/10.1089/thy.2006.16.73

  18. Miyake, T., Ueda, Y., Matsuzaki, S., Miyatake, T., Yoshino, K.,Fujita, M., Nomura, T., Enomoto, T. & Kimura, T. (2011).CRABP1-reduced expression is associated with poorerprognosis in serous and clear cell ovarian adenocarcinoma.J. Cancer Res. Clin. Oncol., 137(4), 715–722. https://doi.org/10.1007/s00432-010-0930-8

  19. Moreno-Navarrete, J. M. & Fernández-Real, J. M. (2017).Adipocyte Differentiation. In M. E. Symonds (Ed.),Adipose Tissue Biology (pp. 69–90). Springer InternationalPublishing. https://doi.org/10.1007/978-3-319-52031-5_3

  20. Muscogiuri, G., Sorice, G. P., Mezza, T., Prioletta, A., Lassandro,A. P., Pirronti, T., Casa, S. della, Pontecorvi, A. & Giaccari,A. (2013). High-normal TSH values in obesity: Is itinsulin resistance or adipose tissue’s guilt?. Obesity, 21(1),101–106. https://doi.org/10.1038/oby.2012.157

  21. Nagpal, I. & Wei, L. N. (2019). All-trans retinoic acid as aversatile cytosolic signal modulator mediated by CRABP1.Int. J. Mol. Sci., 20(15), 1–11. https://doi.org/10.3390/ijms20153610

  22. Napoli, J. L. (2017). Cellular retinoid binding-proteins, CRBP,CRABP, FABP5: Effects on retinoid metabolism, functionand related diseases. Pharmacol. Ther., 173, 19–33. https://doi.org/10.1016/j.pharmthera.2017.01.004

  23. Nautiyal, J., Christian, M. & Parker, M. G. (2013). Distinctfunctions for RIP140 in development, inflammation, andmetabolism. Trends Endocrinol. Metab., 24(9), 451–459.https://doi.org/10.1016/j.tem.2013.05.001

  24. Nhieu, J., Lin, Y.-L. & Wei, L.-N. (2022). CRABP1 in Non-Canonical Activities of Retinoic Acid in Health andDiseases. Nutrients, 14(7), 1528. https://doi.org/10.3390/nu14071528.

  25. Nishiwaki, M., Yamamoto, T., Tone, S., Murai, T., Ohkawara,T., Matsunami, T., Koizumi, M., Takagi, Y., Yamaguchi,J., Kondo, N., Nishihira, J., Horikawa, T. & Yoshiki, T.(2008). Genotyping of human papillomaviruses by a novelone-step typing method with multiplex PCR and clinicalapplications. J. Clin. Microbiol., 46(4), 1161–1168. https://doi.org/10.1128/JCM.00793-07.

  26. Park, S. W., Huang, W. H., Persaud, S. D. & Wei, L. N.(2009). RIP140 in thyroid hormone-repression andchromatin remodeling of Crabp1 gene during adipocytedifferentiation. Nucleic Acids Res., 37(21), 7085–7094.https://doi.org/10.1093/nar/gkp780

  27. Persaud, S. D., Park, S. W., Ishigami-Yuasa, M., Koyano-Nakagawa, N., Kagechika, H. & Wei, L.-N. (2016). Alltrans-retinoic acid analogs promote cancer cell apoptosisthrough non-genomic Crabp1 mediating ERK1/2phosphorylation. Sci. Rep., 6(1), 22396. https://doi.org/10.1038/srep22396

  28. Pfaffl, M. W. (2001). A new mathematical model for relativequantification in real-time RT-PCR. Nucleic Acids Res.,

  29. 29(9), 2002–2007. https://doi.org/10.1093/nar/29.9.e4529. Pfoertner, S., Goelden, U., Hansen, W., Toepfer, T., Geffers,R., Ukena, S. N., von Knobloch, R., Hofmann, R., Buer,J. & Schrader, A. J. (2005). Cellular retinoic acid bindingprotein I: Expression and functional influence in renalcell carcinoma. Tumour Biol., 26, 313–323. https://doi.org/10.1159/000089262

  30. Poorolajal, J. & Jenabi, E. (2016). The association betweenBMI and cervical cancer risk : a meta-analysis. Eur. J.Cancer Prev., 25(3), 232–238. https://doi.org/https://doi.org/10.1097/CEJ.0000000000000164

  31. Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y. F., Klein,R. S. & Burk, R. D. (1997). PCR detection of humanpapillomavirus: Comparison between MY09/MY11 andGP5+/GP6+ primer systems. J. Clin. Microbiol., 35(6),1304–1310. https://doi.org/10.1128/jcm.35.6.1304-1310.1997

  32. Sakata, K., Kanda, M., Shimizu, D., Nakamura, S., Inokawa,Y., Hattori, N., Hayashi, M., Tanaka, C., Nakayama, G.& Kodera, Y. (2022). Expression of cellular retinoic acidbinding protein 1 predicts peritoneal recurrence of gastriccancer. Int. J. Oncol., 60(6), 63. https://doi.org/10.3892/ijo.2022.5353

  33. Soprano, D. R. (1994). Serum and Cellular retinoid-bindingproteins. In K. Dakshinamurti (Ed.), Vitamin Receptors.Vitamins as Ligands in Cell Communication: Vol. XXXIII(Issue 2, pp. 81–87). Cambridge University Press. https://doi.org/10.1017/CBO9780511525391.003

  34. Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M.& Meijer, C. J. L. M. (2014). Clinical implications of (epi)genetic changes in HPV-induced cervical precancerouslesions. Nat. Rev. Cancer, 14(6), 395–405. https://doi.org/10.1038/nrc3728

  35. Tanaka, K., Imoto, I., Inoue, J., Kozaki, K., Tsuda, H., Shimada,Y., Aiko, S., Yoshizumi, Y., Iwai, T., Kawano, T. & Inazawa,J. (2007). Frequent methylation-associated silencing ofa candidate tumor-suppressor, CRABP1, in esophagealsquamous-cell carcinoma. Oncogene, 26(44), 6456–6468.https://doi.org/10.1038/sj.onc.1210459

  36. Tannous-Khuri, L., Hillemanns, P., Rajan, N., Wright, T. C. &Talmage, D. A. (1994). Expression of Cellular RetinoicAcid-Binding Cervical Epithelium Is Stimuli DuringNormal Retinol- and Cellular Proteins in the Rat Regulatedby Endocrine Squamous Metaplasia. Am. J. Pathol., 144(1),148–159. https://pubmed.ncbi.nlm.nih.gov/8291604/

  37. The Human Protein Atlas (March, 2023a). Tissue expressionof CRABP1 Staining in cervix. The Human ProteinAtlas. https://www.proteinatlas.org/ENSG00000166426-CRABP1/tissue/cervix.

  38. The Human Protein Atlas (March, 2023b). Expression ofCRABP1 in cervical cancer .The Human Protein Atlas.https://www.proteinatlas.org/ENSG00000166426-CRABP1/pathology/cervical+cancer#ihc

  39. Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C.,Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C.,Sjöstedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg,E., Navani, S., Szigyarto, C. A., Odeberg, J., Djureinovic,D., Takanen, J. O., Hober, S., Alm, T., Edqvist, P.H., Berling,H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk,J.M., Hamsten, M., von Feilitzen, K., Forsberg, M., Persson,L., Johansson, F., Zwahlen, M., von Heijne, G., Nielsen, J.& Pontén, F. (2015). Proteomics. Tissue-based map of thehuman proteome. Science, 347(6220), 1260419. https://doi.org/10.1126/science.1260419.

  40. Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L.,Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors,F., Sanli, K., von Feilitzen, K., Oksvold, P., Lundberg,E., Hober, S., Nilsson, P., Mattsson, J., Schwenk, J. M.,Brunnström, H., Glimelius, B., Sjöblom, T., Edqvist, P.H.,Djureinovic, D., Micke, P., Lindskog, C., Mardinoglu, A.& Ponten, F. (2017). A pathology atlas of the human cancertranscriptome. Science, 357(6352), eaan2507. https://doi.org/10.1126/science.aan2507

  41. Vattai, A., Cavailles, V., Sixou, S., Beyer, S., Kuhn, C., Peryanova,M., Heidegger, H., Hermelink, K., Mayr, D., Mahner, S.,Dannecker, C., Jeschke, U. & Kost, B. (2017). Investigationof RIP140 and LCoR as independent markers for poorprognosis in cervical cancer. Oncotarget, 8(62), 105356–105371. https://doi.org/10.18632/oncotarget.22187

  42. Vogelsang, T. L. R., Schmoeckel, E., Kuhn, C., Blankenstein,T., Temelkov, M., Heidegger, H., Kolben, T. M., Kolben,T., Mahner, S., Mayr, D., Jeschke, U. & Vattai, A.(2020). Regulation of LCoR and RIP140 expression incervical intraepithelial neoplasia and correlation withCIN progression and dedifferentiation. J. Cancer Res.Clin. Oncol., 146(7), 1847–1855. https://doi.org/10.1007/s00432-020-03178-x.

  43. Wei, L. N., Lee, C. H., Filipcik, P. & Chang, L. (1997). Regulationof the mouse cellular retinoic acid-binding protein-I gene bythyroid hormone and retinoids in transgenic mouse embryosand P19 cells. J. Endocrinol., 155(1), 35–46. http://www.ncbi.nlm.nih.gov/pubmed/9390004

  44. Wei, L.-N. (2012). Chromatin remodeling and epigeneticregulation of the CrabpI gene in adipocyte differentiation.Biochim. Biophys. Acta, 1821(1), 206–212. https://doi.org/10.1016/j.bbalip.2011.03.003.




2020     |     www.medigraphic.com